The firm is scrutinizing the terms of these transactions to determine if they unfairly limit competition or fail to provide adequate compensation. The investigation centers on Lifecore Biomedical’s sale to Webster Equity Partners at $6.28 per share, alongside a non-tradable contingent value right, and Integer Holdings’ $127.00 per share acquisition by KKR. Additionally, the firm is reviewing the mergers of First Hawaiian with TriCo Bancshares and Indivior Pharmaceuticals with Supernus Pharmaceuticals.

Halper Sadeh LLC aims to secure increased consideration or improved disclosures for investors, citing concerns over potential federal securities law violations. The firm operates on a contingent fee basis, representing global shareholders in cases of corporate misconduct and seeking to implement institutional reforms. Attorneys Daniel Sadeh and Zachary Halper are leading the inquiries from their One World Trade Center office in New York.